Financial overview

Immunovia financial report data and keyfigures. History for income statement, balance sheet and cash flow.

Pre
Pre

Description

Immunovia AB molecular diagnostic company. It develops and commercializes diagnostic tools for complex forms of cancer and autoimmune diseases. Its technology platform IMMray (TM), is based on antibody microarray analysis. The group's intangible and tangible assets are in Sweden, in the United States and in Germany.

Medical Equipment